Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonneveld

Showing results (1-10 of 1,271) with videos related to

Pageof 128
Sort By:
Seminars in Oncology|April 1, 1992
Teniposide in lymphomas and leukemiasP Sonneveld
Hematology. American Society of Hematology. Education Program|December 10, 2017
Management of multiple myeloma in the relapsed/refractory patientPieter Sonneveld
Blood|April 11, 2009
Thalidomide/dexamethasone in myeloma: a double-edged swordPieter Sonneveld
Bailliere'S Clinical Haematology|March 1, 1996
Multidrug resistance in acute myeloid leukaemiaP Sonneveld
European Journal of Cancer (Oxford, England : 1990)|June 1, 1996
Reversal of multidrug resistance in acute myeloid leukaemia and other haematological malignanciesP Sonneveld
Hemasphere|April 21, 2020
EHA Scientific Working Groups: Connecting Science and Spreading Knowledge in HematologyPieter Sonneveld
The Netherlands Journal of Medicine|October 9, 2002
Tumour lysis syndrome in myelomaP Sonneveld
Bailliere'S Clinical Haematology|December 1, 1995
Modulation of multidrug resistance in multiple myelomaP Sonneveld
Journal of Internal Medicine|May 16, 2000
Multidrug resistance in haematological malignanciesP Sonneveld
Cancer Treatment Reports|July 1, 1978
Effect of alpha-tocopherol on the cardiotoxicity of adriamycin in the ratP Sonneveld
Pageof 128

Showing results (1-10 of 1,271) with videos related to

Sort By:
Pageof 128
Seminars in Oncology|April 1, 1992
Teniposide in lymphomas and leukemiasP Sonneveld
Hematology. American Society of Hematology. Education Program|December 10, 2017
Management of multiple myeloma in the relapsed/refractory patientPieter Sonneveld
Blood|April 11, 2009
Thalidomide/dexamethasone in myeloma: a double-edged swordPieter Sonneveld
Bailliere'S Clinical Haematology|March 1, 1996
Multidrug resistance in acute myeloid leukaemiaP Sonneveld
European Journal of Cancer (Oxford, England : 1990)|June 1, 1996
Reversal of multidrug resistance in acute myeloid leukaemia and other haematological malignanciesP Sonneveld
Hemasphere|April 21, 2020
EHA Scientific Working Groups: Connecting Science and Spreading Knowledge in HematologyPieter Sonneveld
The Netherlands Journal of Medicine|October 9, 2002
Tumour lysis syndrome in myelomaP Sonneveld
Bailliere'S Clinical Haematology|December 1, 1995
Modulation of multidrug resistance in multiple myelomaP Sonneveld
Journal of Internal Medicine|May 16, 2000
Multidrug resistance in haematological malignanciesP Sonneveld
Cancer Treatment Reports|July 1, 1978
Effect of alpha-tocopherol on the cardiotoxicity of adriamycin in the ratP Sonneveld
Pageof 128